Dupont Capital Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-13,744
| Closed | -$690K | – | 1504 |
|
|
2022
Q3 | $690K | Buy |
13,744
+5,119
| +59% | +$257K | 0.04% | 525 |
|
|
2022
Q2 | $346K | Hold |
8,625
| – | – | 0.02% | 831 |
|
|
2022
Q1 | $322K | Sell |
8,625
-763
| -8% | -$28.5K | 0.01% | 905 |
|
|
2021
Q4 | $374K | Sell |
9,388
-3,743
| -29% | -$149K | 0.01% | 908 |
|
|
2021
Q3 | $489K | Sell |
13,131
-1,858
| -12% | -$69.2K | 0.02% | 881 |
|
|
2021
Q2 | $634K | Hold |
14,989
| – | – | 0.02% | 856 |
|
|
2021
Q1 | $710K | Sell |
14,989
-3,074
| -17% | -$146K | 0.02% | 748 |
|
|
2020
Q4 | $1.1M | Sell |
18,063
-1,348
| -7% | -$82.2K | 0.02% | 515 |
|
|
2020
Q3 | $907K | Sell |
19,411
-1,301
| -6% | -$60.8K | 0.02% | 547 |
|
|
2020
Q2 | $1.05M | Sell |
20,712
-6,283
| -23% | -$319K | 0.02% | 495 |
|
|
2020
Q1 | $1.2M | Buy |
26,995
+620
| +2% | +$27.7K | 0.03% | 402 |
|
|
2019
Q4 | $1.27M | Buy |
26,375
+8,658
| +49% | +$416K | 0.03% | 494 |
|
|
2019
Q3 | $599K | Sell |
17,717
-1,900
| -10% | -$64.2K | 0.01% | 708 |
|
|
2019
Q2 | $883K | Buy |
19,617
+7,876
| +67% | +$355K | 0.02% | 581 |
|
|
2019
Q1 | $442K | Hold |
11,741
| – | – | 0.01% | 805 |
|
|
2018
Q4 | $403K | Buy |
+11,741
| New | +$403K | 0.01% | 808 |
|